Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.Braun Medical Inc, Bethlehem, PA. 18018-3524 USA. NDC 0264-9587-20.
Published March 15, 2023 · Recall initiated: March 1, 2023
Summary
FDA records drug Class II recall D-0434-2023, published March 15, 2023 and initiated March 1, 2023. Recalling firm: B. Braun Medical Inc; Status: Terminated; Reported quantity: 30672; Lot: Lot J2C017; Expiration: 9/30/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: low Anti-Factor IIa potency.
What to do
Letter
Get an email if HEPARIN SODIUM IN DEXTROSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HEPARIN SODIUM IN DEXTROSE
- Manufacturer
- B. Braun Medical Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot J2C017; Expiration: 9/30/2023.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHeparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml ExcelMay 24, 2023
- FDABrimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDCMarch 15, 2023
- FDAHeparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For IntravenousMarch 15, 2023
- FDAVerapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10),March 15, 2023
- FDACustom Suture Pack Product Description: US1638 CUSTOM SUTURE PACK US1756 CUSTOM SUTURE PACKMarch 8, 2023
- FDAHeparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCELJune 19, 2019
Questions about this recall
Was Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.Braun Medical Inc, Bethlehem, PA. 18018-3524 USA. NDC 0264-9587-20. recalled?
Yes. FDA published recall D-0434-2023 on March 15, 2023. Reported hazard: Subpotent Drug: low Anti-Factor IIa potency.
What should I do if I have this product?
Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HEPARIN SODIUM IN DEXTROSE.